CAR T therapy (chimeric antigen receptor therapy) is a new treatment strategy that has been shown to improve patient outcomes. In this lecture, Dr. William reviews the steps involved, including T-cell collection, lymphodepleting chemotherapy, reinfusion of T-cells, and follow-up care. Potential side effects and their treatments are discussed as wel

A transplant using the patient's own stem cells (an autologous stem cell transplant) or CAR T-cell therapy are treatment options for patients with certain types of lymphoma.

CAR T-cell therapy is a new treatment option for lymphoma patients whose disease has been resistant to standard chemotherapy. This presentation describes what’s involved in going through CAR T-cell therapy, the CAR T-cell products currently approved by the FDA, and the short- and long-term side effects of treatment.

There are several safe and effective vaccines for COVID-19. These vaccines are recommended for transplant patients in most circumstances. This presentation reviews guidelines, offers recommendations, and answers questions about the benefits of COVID-19 vaccines for transplant patients.

A stem cell transplant is a treatment option for some lymphoma patients who are at risk of relapsing after standard chemotherapy. CAR-T therapy is a new type of immunotherapy that is available to patients with B-cell lymphoma who relapsed or did not obtain a remission after standard chemotherapy.